1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. SHALBY LTD.
Shalby Ltd.
NSE: SHALBY | BSE: 540797

Shalby Live Share Price Today, Share Analysis and Chart

aboutShalby Ltd. is a multi-specialty healthcare provider and a global leader in joint replacement surgeries. Based in Ahmedabad, India, the company operates a network of multi-specialty hospitals and has diversified into the medical consumables and impla... Read More
Ask AI about Shalby
120.64-1.32(-1.08%)
53,502
NSE+BSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Mid-range PerformerThese stocks have affordable valuations, but mid range financials and momentumView SimilarEmbed DVM

Shalby Stock Price Analysis

Day Price Range

-1.1% 1 Day return
120.6 (LTP)
119.8122
LowHigh

Week Price Range

6.4% 1 Week return
120.6 (LTP)
112126.9
LowHigh

Month Price Range

-9.7% 1 Month return
120.6 (LTP)
110.6137.1
LowHigh

52 Week Price Range

-50.0% 1 Year return
120.6 (LTP)
110.6252
LowHigh

Shalby Technical Analysis

Shalby EMA & SMA

Bearish-6
1 bullish, 7 bearish
Bullish1
Bearish7
5 Day120.6
10 Day121.9
12 Day122.8
20 Day126.4
26 Day128.9
50 Day136.9
100 Day147.0
200 Day160.1

Shalby Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202650.4%
Week57.6%
Month58.1%
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Shalby Resistance and Support

120.82
Pivot
First Resistance121.8
Second Resistance123.0
Third Resistance124.0
First Support119.7
Second Support118.7
Third Support117.5
Day RSI36.7
Day MACD-6.1
Day MFI25.7
Day MACD Signal Line-6.2

Shalby Beta

1 Month0.9
1 Year1.4
3 Month1.1
3 Year1.2

Shalby Price Change Analysis

↓-9.7%
Over 1 Month
LowHigh
110.6137.1
↓-25.2%
Over 3 Months
LowHigh
110.6169.0
↓-24.9%
Over 6 Months
LowHigh
110.6182.3
↓-50%
Over 1 Year
LowHigh
110.6252.1

Shalby Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Shah Family Trust Throuh Dr. Vikram Shah, TrusteePromoter37,577,13234.8 %
First Water FundFii1,951,1381.8 %
HufPublic844,1920.8 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Shalby Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
GRAVITON RESEARCH CAPITAL LLPBulkSell22 Sep 2025266.551,354,105NSE
GRAVITON RESEARCH CAPITAL LLPBulkPurchase22 Sep 2025266.341,354,105NSE
MUSIGMA SECURITIESBulkSell05 Sep 2025223.36548,438NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDBulkSell05 Sep 2025223.57568,902NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDBulkPurchase05 Sep 2025223.40568,902NSE
MUSIGMA SECURITIESBulkPurchase05 Sep 2025223.24548,438NSE
HARESH TIKAMDAS KASWANIBlockSell13 Jun 2025180700,000NSE
FIRST WATER FUNDBlockPurchase13 Jun 2025180700,000NSE
HARESH TIKAMDAS KASWANIBulkSell13 Jun 2025180700,000NSE
FIRST WATER FUNDBulkPurchase13 Jun 2025180700,000NSE

Shalby Corporate Actions

Shalby Dividend history and yield

Shalby dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Shalby dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
119 Sep 2024
1.2FINAL-Equity Share
208 Aug 2023
1.2FINAL-Equity Share
319 Sep 2022
1FINAL-Equity Share
417 Sep 2021
1FINAL-Equity Share
504 Sep 2020
0.5FINAL-Equity Share

Shalby Board Meetings

Shalby past and upcoming board meetings.

#Ex-Date
PurposeNotes
103 Nov 2026
Quarterly Results-
212 Aug 2026
Quarterly Results(Revised)
327 May 2026
Audited Results & Final Dividend-
411 Feb 2026
Quarterly Results-
513 Nov 2025
Quarterly Results-

Shalby Research Reports

Shalby research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
103 Nov 2024ICICI Direct310226.38Buy36.94%-46.71%pdf
214 Jul 2024ICICI Direct
Target
350284.4Buy23.07%-57.58%pdf
307 Apr 2024ICICI Direct320282.1Buy13.43%-57.24%pdf
402 Apr 2024ICICI Direct
Target
320262.7Buy21.81%-54.08%pdf
506 Dec 2023AUM Capital376306.9Buy22.52%-60.69%pdf

Shalby Corporate Filings

Shalby BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
28 Oct 2026
Shalby Ltd - 540797 - Shalby Hospital, Jabalpur Is Now Fully Operational
Intimation u/r. 30 of SEBI LODR
PDF
23 Oct 2026
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Earnings Conference Call to discuss Q2FY2027 earnings
PDF
22 Oct 2026
Shalby Ltd - 540797 - Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For Period Ended On September 30, 2026
Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Board Meeting Intimation
PDF
17 Oct 2026
Shalby Ltd - 540797 - Withdrawal Of Suspension Of Registration Of Shalby Hospital, Jabalpur
Intimation u/r. 30 of SEBI LODR
PDF
14 Oct 2026
Shalby Ltd - 540797 - Intimation U/R. 30 Of SEBI LODR
Intimation u/r. 30 of SEBI LODR
PDF

Shalby DocumentsAsk MarketMind AI

Shalby Earnings Call

Shalby earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
19 Aug 2026Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
13 Aug 2026Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
02 Jun 2026Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
18 Feb 2026Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
14 Aug 2025Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Shalby Annual Reports

Shalby financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026
2025Annual Report Mar-2025
2024Annual Report Mar-2024
2023Annual Report Mar-2023
2022Annual Report Mar-2022

Shalby Credit Ratings

Shalby credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
26 Jul 2026icra ratingsShalby LimitedRating downgraded to [ICRA]A; outlook revised to Stable; rated amount enhanced
05 Jun 2025icra ratingsShalby LimitedUpdate on Material Event; Rating reaffirmed and outlook revised from Stable to Negative
03 Mar 2025icra ratingsShalby LimitedRatings reaffirmed and assigned for enhanced amount
20 Mar 2024icra ratingsShalby LimitedUpdate on Material Event
29 Jan 2024icra ratingsShalby LimitedUpdate on Material Event

Shalby Investor Presentations

Shalby investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
12 Aug 2026Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Investor Presentation
27 May 2026Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Investor Presentation
11 Feb 2026Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Investor Presentation
13 Nov 2025Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Investor Presentation
13 Aug 2025Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Investor Presentation

Shalby - Company Profile

Shalby Management Structure

Shalby management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Tushar D ShahVice President,Company Secretary,Compliance Officer-Mar 26
Mr. Amit KumarChief Financial Officer-Mar 26
Mr. Babu ThomasChief Human Resources Officer(Human Resources)-Mar 26
Dr. Nishita ShuklaGroup Chief Operating Officer-Mar 26
Mr. Viral ShahGeneral Manager(Strategy)-Mar 26
Mr. Shanay ShahPresident(Business Unit)-Mar 26

Shalby Board of Directors

Shalby Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Vikram ShahChairman / Executive Director / M D / Promoter99.3Mar 26
Shyamal S JoshiIndependent Non Exe. Director1.7Mar 26
Umesh MenonIndependent Non Exe. Director1.6Mar 26
Sujana ShahIndependent Non Exe. Director1.6Mar 26
Tej MalhotraIndependent Non Exe. Director1.25Mar 26
Ashok BhatiaIndependent Non Exe. Director1.05Mar 26
Tushar D ShahVP / Company Secretary / Compliance Officer-Mar 26

About the company - Business Profile

Shalby Ltd. is a multi-specialty healthcare provider and a global leader in joint replacement surgeries. Based in Ahmedabad, India, the company operates a network of multi-specialty hospitals and has diversified into the medical consumables and implant manufacturing sectors. Shalby has performed over 1,75,000 joint replacement surgeries to date, establishing one of the largest arthroplasty centers globally.

Key Points

  • Key Facts: Founded in 1994 and headquartered in Ahmedabad, Gujarat, Shalby Ltd. is led by Dr. Vikram Shah (Chairman and Managing Director). The company is listed on both the BSE and NSE.
  • Operations and Resources: The company operates 11 multi-specialty hospitals and 4 single-specialty franchise units across 9 states in Western, Northern, and Central India. As of December 2025, it maintains a total bed capacity of 2,297, with 1,415 operational beds.
  • Market and Significance: Shalby holds a significant market share in Arthroplasty (Joint Replacement), which contributes approximately 33%–36% of its hospital revenue. It also provides high-acuity services in Cardiac Sciences, Oncology, Neurology, and Nephrology.
  • Business Model: Shalby operates a synergistic model combining multi-specialty healthcare services, an asset-light franchise model (SOCE - Shalby Orthopaedic Centre of Excellence), and a MedTech division (implant manufacturing).
  • Revenue Breakdown (FY2025 Annual):
    • Total Consolidated Revenue: ₹1,114.6 crore.
    • Domestic Revenue: ₹1,050 crore.
    • International Revenue: ₹64.6 crore.
  • Segment Revenue (Q2 FY2026):
    • Shalby Hospitals, Pharma & Franchise: 80.9% (₹234.5 crore).
    • Shalby MedTech (Implants): 11.6% (₹33.7 crore).
    • Shalby International (Delhi-NCR): 6.9% (₹19.9 crore).
  • Geographical and Payor Mix:
    • Payor Mix (Q3 FY2026): TPA/Insurance (35%), Self-Pay (35%), Government (30%).
    • Geographic Focus: Stronghold in Gujarat and Rajasthan, with recent expansion into Delhi-NCR via the acquisition of PK Healthcare (Sanar International Hospital).
  • Products and Technology: Key products include knee and hip implants manufactured through its MedTech division. The company utilizes advanced EBUS systems and radiotherapy machines. It has 24 ongoing clinical research trials and 42 in the pipeline as of Q4 FY2025.
  • Operational Metrics (FY2025):
    • In-patient Count: 56,788.
    • Out-patient Count: 5,40,119.
    • Occupancy Rate: 47% (on operational beds).
    • ARPOB (Average Revenue Per Operating Bed): ₹41,377.
    • ALOS (Average Length of Stay): 3.65 days.
  • Subsidiaries: Key units include Shalby MedTech (formerly Mars Medical Devices), Shalby Advanced Technologies Inc. (USA), and Shalby Global Technologies (Singapore).
  • Strategic Initiatives and Outlook: Shalby is focusing on a grow smart strategy, prioritizing asset utilization and high-acuity specialty hubs (Oncology, Transplants) over rapid physical expansion. Future growth is targeted through the SOCE franchise model and international medical tourism, particularly in the Delhi-NCR facility.

References

  1. Annual Report May 2025
  2. Investor Presentation Feb 2026
  3. Investor Presentation Nov 2025
  4. Annual Report May 2024

Shalby FAQ

Shalby today is trading in the red, down by 1.08% at ₹120.64.
Shalby is currently trading down 1.08% on an intraday basis. In the past week the stock rose 6.39%. Stock has been down 25.21% in the past quarter and fell 50% in the past year. You can view this in the share price history/seasonality section.
Shalby is listed on NSE with the ticker SHALBY and on BSE as 540797. It's currently trading on NSE at a share price of ₹120.64 and on BSE with a share price of ₹121.
The market cap of Shalby is ₹1,303.03 Cr. as of Oct 30, 2026.
Shalby announced a FINAL dividend of 12% which equals ₹1.2 in Sep 19, 2024.The last three ex-dates for Shalby were Aug 08, 2023, Sep 19, 2022 and Sep 17, 2021. To view the full dividend history of Shalby click here.
Shalby has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.
Shalby reported ₹338.64 Cr. in revenue, ₹10.84 Cr. in net profit, and ₹49 Cr. in EBITD as of Aug 12, 2026 for Q1 FY26-27.
There are no analyst predictions for stock price target for Shalby.
The PE ratio of Shalby is 33.15 as of Oct 30, 2026.
The PB ratio of Shalby is 1.28 as of Oct 30, 2026.
There are no analyst reports for Shalby.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.